
Masimo (MASI) Stock Forecast & Price Target
Masimo (MASI) Analyst Ratings
Bulls say
Masimo is a leader in non-invasive patient monitoring technologies, with a proven track record of delivering high-quality and reliable products. The company's focus on healthcare and expanding its product offerings, including advanced monitoring parameters, should drive continued growth. The recent refinancing and sale of its non-healthcare business reflect positive strategic moves, and the new CEO's focus on marketing and international presence is promising. However, risks include the impact of tariffs and potential delays in new product launches or orders. Masimo's valuation is supported by its historical and industry multiples, with a $198 price target based on a 22x EV/adj.
Bears say
Masimo is expecting high revenue growth in the next few years, citing focus, innovation, and execution as key drivers for this growth. However, potential legal issues with Apple and slow rollout of new products may impact the achievement of these targets. Additionally, the company's op. margin goal may be difficult to reach due to potential tariff impact and strategic reinvestments.
This aggregate rating is based on analysts' research of Masimo and is not a guaranteed prediction by Public.com or investment advice.
Masimo (MASI) Analyst Forecast & Price Prediction
Start investing in Masimo (MASI)
Order type
Buy in
Order amount
Est. shares
0 shares